Scientific Advisory Group on Immune and Inflammatory Diseases

The Scientific Advisory Group on Immune and Inflammatory Diseases (SAG-IMM)'s role is to provide independent recommendations on scientific, clinical or technical matters to the European Medicine Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP). These recommendations refer to medicines addressing autoimmune, inflammatory diseases, respiratory and dermatological diseases, or any other scientific issues. The scientific advisory group is convened at the request of the CHMP.
HumanMedicines

The Scientific Advisory Group on Immune and Inflammatory Diseases provides recommendations for medicines under CHMP evaluation. 

These include medicines for autoimmune and inflammatory diseases like immunodeficiencies, rheumatology, transplantation and allergies. They also refer to medicines for respiratory and dermatological diseases.

The group's recommendations also cover other scientific issues relevant to the CHMP's work in this field.

For more information on CHMP working parties and group, see: 

Mandate, rules of procedure and work programme

Information on the group's mandate, objectives and rules of procedure is available below:

Composition

The group is composed of independent European experts selected according to their specific expertise. 

It comprises a core group of experts and other individual experts who may be called upon to participate in a given meeting and bring additional expertise in specific domains.

Members

Below (in alphabetical order of surname) are the current members of the SAG-IMM. The members' declarations of interests are available in the European expert list.

  • Raffaele Badolato
  • Isidora Binikou
  • Hans Henrik Lawaetz Schultz
  • Tania Masmas
  • Tim Niehues
  • Krista Ress
  • Valentin S. Schäfer
  • Klaus Tenbrock 

Share this page